Navigation Links
Breakthrough Isolaz(TM) Acne Therapy Featured in U.S. News & World Report:

Aesthera Isolaz Therapy described as 'Advance Against Acne'

PLEASANTON, Calif., June 10 /PRNewswire/ -- Aesthera Corporation's Isolaz(TM) painless acne therapy has been featured in the June 9, 2008, issue of U.S. News & World Report, a leading national weekly news magazine. The publication describes Isolaz(TM) acne therapy as "an advance against acne" and reports that the Isolaz is the first treatment device FDA cleared to treat comedonal and pustular acne, in addition to mild to moderate, inflammatory acne and acne vulgaris.

Discussing clinical outcomes, the article explains the Isolaz(TM) system's effectiveness on patients of all ages, who have struggled with acne and have failed traditional therapies including topicals and antibiotics. Gilly Munavalli, MD, MHS, Director of Dermatology, Laser, and Veins Specialists of the Carolinas in Charlotte, NC and Clinical Instructor of Dermatology at Johns Hopkins University School of Medicine, notes that while the Isolaz also works on non-responders to traditional acne therapies, a greater benefit of the treatment is the rapid improvement relative to drugs.

The article describes a 22-year-old patient's struggle with acne and her 100% clinical, emotional and functional improvement post Isolaz(TM) treatments. Dermatologist Dale Isaacson, MD expresses great satisfaction with Isolaz system's efficacy noting that the device works in about 90% of his patients.

In addition to this breakthrough painless therapy for acne, Aesthera's Isolaz(TM) system is also FDA cleared to treat skin rejuvenation, including the treatment of vascular and pigmented lesions as well as hair removal on all skin types.

Prior to its coverage by U.S. News & World Report, Isolaz(TM) therapy has also been recently featured in the New York Times and Wall Street Journal. It has also been covered by Vogue, Elle, Allure, Shape, Bazaar, Self, and the June 2008 issues of Marie Claire and Family Circle, as a breakthrough acne treatment that also successfully and effectively minimizes and clears pores on a long-term basis.

To learn where you can receive an Isolaz(TM) treatment or to receive more information on the Isolaz(TM) System please visit

About Aesthera Corporation

Aesthera ( develops, manufactures and markets light-based aesthetic treatment systems based on proprietary Photopneumatic(TM) (PPx(TM)) technology. Clinically proven to be pain-free and up to seven times faster than currently available light-based aesthetic systems, Aesthera's revolutionary systems combine the proven properties of therapeutic light with gentle pneumatic energy to more effectively work on dermal and epidermal skin targets.

SOURCE Aesthera Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. A New Home for Medical Breakthroughs
2. Yales Scassellati gets Microsoft breakthrough research award for robotics
3. Innolife Pharma Inc. acquires rights to breakthrough in non-narcotic chronic pain treatment
4. Renowned ENT Specialist, Dr. Murray Grossan, Announces Medical Breakthrough on Snoring at PRI-MED Convention in Anaheim on May 15-17
5. Dental Convention to Highlight Latest Breakthroughs in Oral Health Treatments
6. Medical Breakthrough Reaches America
7. Tiny magnets offer breakthrough in gene therapy for cancer
8. New Breakthrough Treatment is Tough On Lice But Gentle On Kids
9. Key found to breakthrough drug for clot victims
10. Breakthrough Seating Technology, ergoSEET(TM), Now Available in Indianapolis
11. Breakthrough in birth-defect research
Post Your Comments:
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... a safe and convenient way to dispense prescription medications at home, so he ... effective way to monitor and dispense prescription medications. In doing so, it could ...
(Date:11/27/2015)... ... , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of ... than 3.7 billion people under the age of 50 – or 67% of the population ... global estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... an innovative online platform for mental health and wellness consultation, has collaborated with ... partnership will bridge the knowledge gap experienced by parents and bring advice from ...
(Date:11/27/2015)... ... 27, 2015 , ... Indosoft Inc., developer and distributor of ... 11 LTS (Long Term Support) into its Q-Suite 5.10 product line. , Making ... with a version of Asterisk that will receive not only security fixes, but ...
(Date:11/26/2015)... ... ... The Catalent Applied Drug Delivery Institute today announced a ... selection in early phase drug development. The first of these is to be ... UK’s emerging life sciences companies, corporate partners, and investors, at Milton Park, Oxford, ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... STOCKHOLM , November 26, 2015 ... the potential to use SyMRI to find optimal contrast weighting ... brain tumor metastases, and has signed a research agreement with ... at the hospital. Using SyMRI, it is possible to generate ... parameter settings after the patient has left, thus making it ...
(Date:11/26/2015)... 2015 ) ... "2016 Future Horizons and Growth Strategies in ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> ) has announced ... Horizons and Growth Strategies in the French ...
(Date:11/26/2015)... DUBLIN , Nov. 26, 2015 Research ... of the "Advanced Wound Care Market by Type ... Ulcers), End User (In-Patient Facility, Out-Patient Facility), and Geography ... offering. --> --> ... the description, definition and forecast of the global advanced ...
Breaking Medicine Technology: